- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04049708
Intrarater and Interrater Reliability Physical Function Measures in HD BCN (ReliabilityBCN)
August 30, 2019 updated by: Eva Segura Ortí, Cardenal Herrera University
Intrarater Reliability in Different Days and Interrater Reliability of Physical Function Assessment in HD Patients
The investigators will calculate values of absolute and relative reliability for intrarater reliability when the measures are taken during a hemodialysis treatment day and during a non-dialysis day.
Interrater reliability between two different observers will be also calculated
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients suffering from End Stage Renal Disease are commonly involved in haemodialysis treatment, which is the most common treatment at this stage.
Haemodialysis substitutes the renal function but is associated with several alterations that lead to decrease in functional capacity.
Many studies show that functional capacity is significantly worse than their healthy sedentary age - matched counterparts.
The purpose of the present study is to calculate values of absolute and relative intrarater reliability (dialysis vs non dialysis day) and interrater reliability of different physical function measures (Short Physical Performance Battery, one-leg balance, Timed Up and go, sit to stand to sit tests, triceps and handgrip strength, six-minute walking test).
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Barcelona
-
Terrassa, Barcelona, Spain, 08227
- Hospital de Terrassa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
People with Chronic Kidney Diseases undergoing hemodialysis treatment
Description
Inclusion Criteria:
- At least 3 months in hemodialysis treatment
- Clinically stable
Exclusion Criteria:
- Recent cardiac events (less than 3 months)
- Unable to exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Short Physical Performance Battery at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Assess lower extremity, which includes objective performance-based measure of balance (side-by-side, semitandem and tandem), endurance (4m gait speed) and strength (five chair stands).
Each component was scored from 0 to 4 and when summed yielded SPPB scores between 0 (poor) and 12 (best).
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Gait speed at one week at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Speed to cover 4 meters, in meters/second
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Change from baseline One-leg standing test at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Time achieved while standing on one leg
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Change from baseline Timed up and go at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Time to stand up, walk 3 meters, come back and sit down again
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Change from baseline Sit to stand 10 test at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Time to perform 10 repetitions sit to stand
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Change from baseline Sit to stand 60 test at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Sit to stand repetitions performed in 60 seconds
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Change from baseline One-leg heel rise test at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Number of heel rise repetitions achieved
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Change from baseline 6 minutes walk test at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Number of meters walked in 6 minutes
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Change from baseline Handgrip at one week
Time Frame: It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Bilateral handgrip strength
|
It will perform the test three times with one week interval between the testing sessions, one before hemodialysis, and the other one next week during a non-dialysis day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Esteve Simo V, Junque Jimenez A, Moreno Guzman F, Carneiro Oliveira J, Fulquet Nicolas M, Pou Potau M, Saurina Sole A, Duarte Gallego V, Tapia Gonzalez I, Ramirez de Arellano M. Benefits of a low intensity exercise programme during haemodialysis sessions in elderly patients. Nefrologia. 2015;35(4):385-94. doi: 10.1016/j.nefro.2015.03.006. Epub 2015 Jul 21. English, Spanish.
- Segura-Orti E, Martinez-Olmos FJ. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis. Phys Ther. 2011 Aug;91(8):1244-52. doi: 10.2522/ptj.20100141. Epub 2011 Jun 30.
- Ortega-Perez de Villar L, Martinez-Olmos FJ, Junque-Jimenez A, Amer-Cuenca JJ, Martinez-Gramage J, Mercer T, Segura-Orti E. Test-retest reliability and minimal detectable change scores for the short physical performance battery, one-legged standing test and timed up and go test in patients undergoing hemodialysis. PLoS One. 2018 Aug 22;13(8):e0201035. doi: 10.1371/journal.pone.0201035. eCollection 2018.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 7, 2019
Primary Completion (Actual)
August 29, 2019
Study Completion (Actual)
August 29, 2019
Study Registration Dates
First Submitted
August 5, 2019
First Submitted That Met QC Criteria
August 6, 2019
First Posted (Actual)
August 8, 2019
Study Record Updates
Last Update Posted (Actual)
September 3, 2019
Last Update Submitted That Met QC Criteria
August 30, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ReliabilityBCN
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Disease on Dialysis
-
Peripal AGUniversity Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...CompletedRenal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisUnited Kingdom
-
Satellite HealthcareCompletedEnd Stage Renal Disease on Dialysis | Home DialysisUnited States
-
Sun Yat-sen UniversityRecruiting
-
Nanyang Technological UniversityNational Kidney Foundation, SingaporeRecruitingEnd Stage Renal Disease | End Stage Kidney Disease | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisSingapore
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
Centre Hospitalier Universitaire de BesanconRecruitingPeritoneal Dialysis | End Stage Renal Disease on DialysisFrance
-
Kaohsiung Medical University Chung-Ho Memorial...National Sun Yat-sen UniversityRecruiting
-
RenJi HospitalNot yet recruitingEnd Stage Renal Disease on DialysisChina
-
Réseau de Santé Vitalité Health NetworkUnknownEnd Stage Renal Disease on DialysisCanada
-
University of AarhusCompletedEnd Stage Renal Disease on DialysisDenmark
Clinical Trials on Reliability of physical function
-
University of New MexicoNational Cancer Institute (NCI)Active, not recruiting
-
Universidad Europea de MadridHospital Universitario Ramon y CajalNot yet recruitingDeglutition Disorders | Mechanical Ventilation Complication | Dysphagia, Oropharyngeal
-
University of Castilla-La ManchaConsorcio Centro de Investigación Biomédica en Red (CIBER)RecruitingAging | Physical Disability | Frailty Syndrome | Physical Function | Lifestyle, SedentarySpain
-
Hacettepe UniversityCompletedBurn Scar | Burns | Lower Limb Injury | Lower Limb WoundTurkey
-
MinYoung Kim, MD, PhDNot yet recruitingPatients With Mild Cognitive Impairment (MCI)
-
Wake Forest University Health SciencesRecruiting
-
M.D. Anderson Cancer CenterCompleted
-
Ohio State University Comprehensive Cancer CenterRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Graft Versus Host DiseaseUnited States
-
GlaxoSmithKlineHealth Research Associates, Inc.CompletedNeoplasmsUnited States